Concepedia

Author

Mei-Ling Siu–Caldera

Women & Infants Hospital of Rhode Island

Also Known As

M L Siu-Caldera, M. L. Siu-Caldera, M.-L Siu-Caldera, M.-L. Siu-Caldera, Mei-Ling Siu-Caldera, Mei-Ling Siu–Caldera

24

Publications

594

Citations

15

H-Index

40

Concepts

All Affiliations

Women & Infants Hospital of Rhode IslandBrown UniversityNortheastern UniversityLa Roche CollegeUniversity of California, Riverside
MS

About

Mei-Ling Siu–Caldera is an author at Women & Infants Hospital of Rhode Island specializing in medicine, pharmacology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

439

2

Biochemistry

8

8

227

3

Cell Biology

8

8

302

4

Health Sciences

2

2

80

5

Natural Sciences

1

1

43

Mei-Ling Siu–Caldera

×

16

Publications

516

Citations

14

H-Index

YearCitations

Differentiation-Related Pathways of 1α,25-Dihydroxycholecalciferol Metabolism in Human Colon Adenocarcinoma-Derived Caco-2 Cells: Production of 1α,25-Dihydroxy-3epi-cholecalciferol

Martin Bischof, Mei-Ling Siu–Caldera, Andrew Weiskopf,

Experimental Cell Research

1998

79

1α,25‐Dihydroxy‐3‐epi‐vitamin D<sub>3</sub>: In vivo metabolite of 1α,25‐dihydroxyvitamin D<sub>3</sub> in rats

H Sekimoto, Mei-Ling Siu–Caldera, Andrew Weiskopf,

FEBS Letters

1999

56

Production of 1α,25-Dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed

Mei-Ling Siu–Caldera, H Sekimoto, Andrew Weiskopf,

Bone

1999

53

Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis

Kimie Nakagawa, Yoshiko Sowa, Mayuko Kurobe,

Steroids

2001

43

Expression of 25(OH)D<sub>3</sub>24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)<sub>2</sub>D<sub>3</sub>and cAMP or PTH

Wen Yang, Peter A. Friedman, Rajiv Kumar,

American Journal of Physiology-Endocrinology and Metabolism

1999

38

Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones.

Mei-Ling Siu–Caldera, Lijun Zou, M G Ehrlich,

Endocrinology

1995

34

1α,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1α,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells

Mei-Ling Siu–Caldera, Jeffrey W. Clark, Anabela Santos-Moore,

The Journal of Steroid Biochemistry and Molecular Biology

1996

33

1α,25-Dihydroxy-16-ene-23-yne-vitamin D3 and 1α,25-Dihydroxy-16-ene-23-yne-20-epi-vitaminD3: Analogs of 1α,25-Dihydroxyvitamin D3 That Resist Metabolism through the C-24 Oxidation Pathway Are Metabolized through the C-3 Epimerization Pathway

G. Satyanarayana Reddy, D.Sunita Rao, Mei-Ling Siu–Caldera,

Archives of Biochemistry and Biophysics

2000

27

Characterization of the metabolic pathway of 1,25-dihydroxy-16-ene vitamin D3 in rat kidney by on-line high performance liquid chromatography-electrospray tandem mass spectrometry

Bernice Yeung, Paul Vouros, Mei-Ling Siu–Caldera,

Biochemical Pharmacology

1995

27

Effects of 1α,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-β estradiol

L.G. Rao, May Kung Sutherland, G.S. Reddy,

Bone

1996

24

Page 1